AZN logo

AstraZeneca (AZN) Company Overview

Profile

Full Name:

AstraZeneca PLC

Sector:

Healthcare

Country:

United Kingdom

IPO:

May 12, 1993

Indexes:

Description:

AstraZeneca (AZN) is a global biopharmaceutical company that focuses on developing and manufacturing medicines for various diseases, including cancer, cardiovascular, and respiratory conditions. They aim to improve patient health through innovative treatments and research, working with healthcare professionals and organizations worldwide.

Key Details

Price

$76.00

Annual Revenue

$54.07 B(+18.03% YoY)

Annual EPS

$2.25(+18.11% YoY)

Beta

0.23

Events Calendar

Earnings

Next earnings date:

Apr 25, 2025

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Feb 6, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 21, 2025
Splits

Next split:

N/A

Recent split:

Jul 27, 2015

Analyst ratings

Recent major analysts updates

Feb 13, 25 UBS
Buy
Nov 20, 24 UBS
Neutral
Sep 11, 24 Erste Group
Buy
Aug 12, 24 TD Cowen
Buy
May 30, 24 Goldman Sachs
Buy
May 30, 24 Argus Research
Buy
Apr 26, 24 BMO Capital
Outperform
Apr 16, 24 Deutsche Bank
Hold
Feb 12, 24 BMO Capital
Outperform
Feb 8, 24 Deutsche Bank
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for AstraZeneca?
  • Does AstraZeneca pay dividends?
  • What sector is AstraZeneca in?
  • What industry is AstraZeneca in?
  • What country is AstraZeneca based in?
  • When did AstraZeneca go public?
  • Is AstraZeneca in the S&P 500?
  • Is AstraZeneca in the NASDAQ 100?
  • Is AstraZeneca in the Dow Jones?
  • When was AstraZeneca's last earnings report?
  • When does AstraZeneca report earnings?
  • Should I buy AstraZeneca stock now?

What is the ticker symbol for AstraZeneca?

The ticker symbol for AstraZeneca is NASDAQ:AZN

Does AstraZeneca pay dividends?

Yes, AstraZeneca pays dividends. The last payment was $1.05, with an ex-dividend date on February 21, 2025

What sector is AstraZeneca in?

AstraZeneca is in the Healthcare sector

What industry is AstraZeneca in?

AstraZeneca is in the Drug Manufacturers - General industry

What country is AstraZeneca based in?

AstraZeneca is headquartered in United Kingdom

When did AstraZeneca go public?

AstraZeneca's initial public offering (IPO) was on May 12, 1993

Is AstraZeneca in the S&P 500?

No, AstraZeneca is not included in the S&P 500 index

Is AstraZeneca in the NASDAQ 100?

Yes, AstraZeneca is included in the NASDAQ 100 index

Is AstraZeneca in the Dow Jones?

No, AstraZeneca is not included in the Dow Jones index

When was AstraZeneca's last earnings report?

AstraZeneca's most recent earnings report was on Feb 6, 2025

When does AstraZeneca report earnings?

The next expected earnings date for AstraZeneca is Apr 25, 2025

Should I buy AstraZeneca stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions